Concepedia

Dafang Zhong

DZ

Statistics

Publications

160

Citations

5.4K

H-Index

38

Active since

1999

Affiliations

Shanghai Institute of Materia Medica(Current)

Chinese Academy of Sciences

Shenyang Pharmaceutical University

University of Chinese Academy of Sciences

Jiangsu Hengrui Medicine (China)

Dafang Zhong is an author at Shanghai Institute of Materia Medica specializing in pharmacology, pharmacy, and mass spectrometric analysis.

Publications per year

1999–2023

160

Publications

160

Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer

Xin Li, Changyong Yang, Hong Wan et al. · European Journal of Pharmaceutical Sciences · 2017 · 227 citations

, , +13

Absorption and enterohepatic circulation of baicalin in rats

Jie Xing, Dafang Zhong · Life Sciences · 2005 · 226 citations

, , +10

Investigation of microemulsion system for transdermal delivery of meloxicam

Yue Yuan, Sanming Li, MO Feng-kui et al. · International Journal of Pharmaceutics · 2006 · 217 citations

, , +14

Metabolism and Pharmacokinetics of 3-n-Butylphthalide (NBP) in Humans: The Role of Cytochrome P450s and Alcohol Dehydrogenase in Biotransformation

Xingxing Diao, Pan Deng, Cen Xie et al. · Drug Metabolism and Disposition · 2012 · 118 citations

, , +17

Metabolism and Pharmacokinetics of Novel Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitor Apatinib in Humans

Juefang Ding, Xiaoyan Chen, Zhiwei Gao et al. · Drug Metabolism and Disposition · 2013 · 106 citations

, , +13

1–5 of 160